{"resourceType":"Bundle","id":"tests-599faf05-2149-4717-a881-1553314a5706-bundle","type":"transaction","entry":[{"fullUrl":"https://madie.cms.gov/Patient/599faf05-2149-4717-a881-1553314a5706","resource":{"resourceType":"Patient","id":"599faf05-2149-4717-a881-1553314a5706","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-patient"]},"extension":[{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-race","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"1002-5","display":"American Indian or Alaska Native","userSelected":true}},{"url":"text","valueString":"American Indian or Alaska Native"}]},{"url":"http://hl7.org/fhir/us/core/StructureDefinition/us-core-ethnicity","extension":[{"url":"ombCategory","valueCoding":{"system":"urn:oid:2.16.840.1.113883.6.238","code":"2135-2","display":"Hispanic or Latino","userSelected":true}},{"url":"text","valueString":"Hispanic or Latino"}]}],"identifier":[{"type":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/v2-0203","code":"MR"}]},"system":"https://bonnie-fhir.healthit.gov/","value":"62fd0e6b85b0356a7c285331"}],"name":[{"family":"DenomFail","given":["PSAAfterStaging"]}],"gender":"other","birthDate":"1980-09-15"},"request":{"method":"PUT","url":"Patient/599faf05-2149-4717-a881-1553314a5706"}},{"fullUrl":"https://madie.cms.gov/Condition/prostate-cancer-a8d8","resource":{"resourceType":"Condition","id":"2f0ecf02-f4e9-4ca0-8c2d-d913138a4d19","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-condition"]},"clinicalStatus":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/condition-clinical","code":"active","display":"active","userSelected":true}]},"category":[{"coding":[{"system":"http://hl7.org/fhir/us/core/CodeSystem/condition-category","code":"health-concern","display":"Health Concern"},{"system":"http://snomed.info/sct","code":"439401001","display":"Diagnosis"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"254900004","display":"Carcinoma of prostate (disorder)","userSelected":true}]},"subject":{"reference":"Patient/599faf05-2149-4717-a881-1553314a5706"},"onsetPeriod":{"start":"2007-06-14T08:00:00.000+00:00"}},"request":{"method":"PUT","url":"Condition/2f0ecf02-f4e9-4ca0-8c2d-d913138a4d19"}},{"fullUrl":"https://madie.cms.gov/Procedure/prostate-cancer-treatment-a8d9","resource":{"resourceType":"Procedure","id":"e80301f6-fcd6-4d5e-a221-a586d63e61cd","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-procedure"]},"extension":[{"url":"http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-recorded","valueDateTime":"2025-02-01T09:00:00.000+00:00"}],"status":"completed","code":{"coding":[{"system":"http://snomed.info/sct","version":"2022-03","code":"10492003","display":"Radionuclide therapy for glandular suppression (procedure)","userSelected":true}]},"subject":{"reference":"Patient/599faf05-2149-4717-a881-1553314a5706"},"performedDateTime":"2025-04-28T08:00:00.000+00:00"},"request":{"method":"PUT","url":"Procedure/e80301f6-fcd6-4d5e-a221-a586d63e61cd"}},{"fullUrl":"https://madie.cms.gov/Observation/prostate-specific-antigen-test-a8db","resource":{"resourceType":"Observation","id":"b1d511eb-a7e1-48f6-88b7-700a117f1f81","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","version":"2.72","code":"10508-0","display":"Prostate specific Ag [Presence] in Tissue by Immune stain","userSelected":true}]},"subject":{"reference":"Patient/599faf05-2149-4717-a881-1553314a5706"},"effectiveDateTime":"2025-08-17T08:00:00.000+00:00","issued":"2025-04-24T08:00:00.000+00:00","valueQuantity":{"value":5.0,"system":"http://unitsofmeasure.org","code":"ng/mL"}},"request":{"method":"PUT","url":"Observation/b1d511eb-a7e1-48f6-88b7-700a117f1f81"}},{"fullUrl":"https://madie.cms.gov/Observation/gleason-score-in-specimen-qualitative-a8dc","resource":{"resourceType":"Observation","id":"89186ad7-a657-44d1-aad0-6590768e58f2","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://loinc.org","code":"35266-6","display":"Gleason score in Specimen Qualitative","userSelected":true}]},"subject":{"reference":"Patient/599faf05-2149-4717-a881-1553314a5706"},"effectiveDateTime":"2025-01-02T08:00:00.000+00:00","valueInteger":5},"request":{"method":"PUT","url":"Observation/89186ad7-a657-44d1-aad0-6590768e58f2"}},{"fullUrl":"https://madie.cms.gov/Observation/tumor-staging-tumor-staging-a8dd","resource":{"resourceType":"Observation","id":"4cf648c8-4b9a-4e78-8779-e8365c1ec20f","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-observation"]},"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"procedure","display":"Procedure"}]}],"code":{"coding":[{"system":"http://snomed.info/sct","code":"254292007","display":"Tumor staging (tumor staging)","userSelected":true}]},"subject":{"reference":"Patient/599faf05-2149-4717-a881-1553314a5706"},"effectiveDateTime":"2025-04-27T23:59:00.000+00:00","valueCodeableConcept":{"coding":[{"system":"http://snomed.info/sct","code":"433351000124101","display":"Neoplasm of prostate primary tumor staging category T1c: Tumor identified by needle biopsy (finding)","userSelected":true}]}},"request":{"method":"PUT","url":"Observation/4cf648c8-4b9a-4e78-8779-e8365c1ec20f"}},{"fullUrl":"https://madie.cms.gov/Coverage/1","resource":{"resourceType":"Coverage","id":"0c685f69-8987-4b09-90c1-c64a976e6f72","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-coverage"]},"status":"active","beneficiary":{"reference":"Patient/599faf05-2149-4717-a881-1553314a5706"},"payor":[{"reference":"Organization/3778262e-e084-4bb5-9a47-1a144735f786"}]},"request":{"method":"PUT","url":"Coverage/0c685f69-8987-4b09-90c1-c64a976e6f72"}},{"fullUrl":"https://madie.cms.gov/Organization/123456","resource":{"resourceType":"Organization","id":"3778262e-e084-4bb5-9a47-1a144735f786","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-organization"]},"identifier":[{"use":"temp","system":"urn:oid:2.16.840.1.113883.4.4","value":"21-3259825"}],"active":true,"type":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/organization-type","code":"pay","display":"Payer"}]}],"name":"Blue Cross Blue Shield of Texas","telecom":[{"system":"phone","value":"(+1) 972-766-6900"}],"address":[{"use":"billing","type":"postal","line":["P.O. Box 660044"],"city":"Dallas","state":"TX","postalCode":"75266-0044","country":"USA"}]},"request":{"method":"PUT","url":"Organization/3778262e-e084-4bb5-9a47-1a144735f786"}},{"fullUrl":"https://madie.cms.gov/Practitioner/practitioner-123456","resource":{"resourceType":"Practitioner","id":"1415e751-0efe-4d21-877a-971db7e477c1","meta":{"profile":["http://hl7.org/fhir/us/qicore/StructureDefinition/qicore-practitioner"]},"identifier":[{"system":"http://hl7.org/fhir/sid/us-npi","value":"123456"}],"name":[{"family":"Evil","prefix":["Dr"]}]},"request":{"method":"PUT","url":"Practitioner/1415e751-0efe-4d21-877a-971db7e477c1"}},{"fullUrl":"https://madie.cms.gov/MeasureReport/354763ba-5575-49da-bd97-5b4543160804","resource":{"resourceType":"MeasureReport","id":"354763ba-5575-49da-bd97-5b4543160804","meta":{"profile":["http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/test-case-cqfm"]},"contained":[{"resourceType":"Parameters","id":"9864e1c0-07aa-407c-9a8a-d28f295d42ee-parameters","parameter":[{"name":"subject","valueString":"599faf05-2149-4717-a881-1553314a5706"}]}],"extension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-inputParameters","valueReference":{"reference":"#9864e1c0-07aa-407c-9a8a-d28f295d42ee-parameters"}},{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-testCaseDescription","valueMarkdown":"Prostate Ca Diagnosis but does not meet  PSA. Meets tumor staging, first treatment, and Gleason.  PSA is after tumor staging. PSA value <10 (5).\n"}],"modifierExtension":[{"url":"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/cqfm-isTestCase","valueBoolean":true}],"status":"complete","type":"individual","measure":"https://madie.cms.gov/Measure/ProstateCaAvoidanceBoneScanOveruseFHIR","period":{"start":"2025-01-01","end":"2025-12-31"},"group":[{"population":[{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"initial-population","display":"Initial Population"}]},"count":1},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator","display":"Denominator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"numerator","display":"Numerator"}]},"count":0},{"code":{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/measure-population","code":"denominator-exception","display":"Denominator Exception"}]},"count":0}]}]},"request":{"method":"PUT","url":"MeasureReport/354763ba-5575-49da-bd97-5b4543160804"}}]}